XTalks

NOVEMBER 10, 2020

HS: Well, a definitive diagnosis opens the door to personalized medicine, potentially leading to reduced morbidity and mortality. It also slows the progress of identifying new disease gene associations in very rare conditions. What are the benefits of having a definitive diagnosis for patients with genetic disorders?

Genome 98

Genome Genomics Medicine Genetic Disease 98

XTalks

SEPTEMBER 28, 2020

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). The liquid biopsy will therefore help personalize medicines for patients based on the molecular features of their disease.

Gene 105

Gene DNA Life Science Genotype 105

pharmaphorum

AUGUST 11, 2022

The program is orchestrated by Coriell Life Sciences, and nearly half of the 5,000 enrolled members have already made immediate shifts to their medication regimen which are showing positive results, both from an individual impact as well as a cost-savings perspective.

Genomics 98

Genomics Genome Drugs Genetics 98

XTalks

JULY 10, 2024

“This simple-to-use test detects the full range of known HCV genotypes in about an hour and can be performed on a small volume of blood collected via fingerstick,” said Dr. David H. Hepatitis C Testing and Treatment Direct-acting antiviral (DAA) medicines are the current standard of care for hepatitis C treatment.

RNA 97

RNA In-Vitro Genotype Marketing 97

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. This includes precision medicine strategies which can be effectively guided through high-level translational research led by clinical data.

Research 98

Research Biobanking Drugs Genomics 98

XTalks

JANUARY 22, 2021

It identifies bacteria using both genotypic and phenotypic assessments within 1.5 The test is geared towards precision medicine for antibiotics in order to target the emergence of antimicrobial resistance. “We The tool can select different combinations of multiple antibiotics deemed suitable for treating specific bacterial infections.

Bacteria 52

Bacteria In-Vitro Genotype Marketing 52

XTalks

APRIL 24, 2023

According to Dr. Melanie Blank, clinical team leader for General Medicine Branch 1 at the US Food and Drug Administration’s (FDA) Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), the agency is seeing one or two new applications coming in every week for new gene therapies for different diseases.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95